These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12384246)

  • 1. Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Rüb U; de Vos RA; Brunt ER; Schultz C; Paulson H; Del Tredici K; Braak H
    Brain Res; 2002 Oct; 953(1-2):126-34. PubMed ID: 12384246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus.
    Rüb U; de Vos RA; Schultz C; Brunt ER; Paulson H; Braak H
    Brain; 2002 Sep; 125(Pt 9):2115-24. PubMed ID: 12183356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Rüb U; Brunt ER; Gierga K; Schultz C; Paulson H; de Vos RA; Braak H
    J Chem Neuroanat; 2003 Feb; 25(2):115-27. PubMed ID: 12663059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions.
    Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T
    Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
    Evert BO; Schelhaas J; Fleischer H; de Vos RA; Brunt ER; Stenzel W; Klockgether T; Wüllner U
    Clin Neuropathol; 2006; 25(6):272-81. PubMed ID: 17140157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degeneration of the central vestibular system in spinocerebellar ataxia type 3 (SCA3) patients and its possible clinical significance.
    Rüb U; Brunt ER; de Vos RA; Del Turco D; Del Tredici K; Gierga K; Schultz C; Ghebremedhin E; Bürk K; Auburger G; Braak H
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):402-14. PubMed ID: 15305986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum.
    Rüb U; Gierga K; Brunt ER; de Vos RA; Bauer M; Schöls L; Bürk K; Auburger G; Bohl J; Schultz C; Vuksic M; Burbach GJ; Braak H; Deller T
    J Neural Transm (Vienna); 2005 Nov; 112(11):1523-45. PubMed ID: 15785863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal inclusions in spinocerebellar ataxia type 3.
    Seidel K; den Dunnen WF; Schultz C; Paulson H; Frank S; de Vos RA; Brunt ER; Deller T; Kampinga HH; Rüb U
    Acta Neuropathol; 2010 Oct; 120(4):449-60. PubMed ID: 20635090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar Ataxia Type 3: A Case Report and Literature Review.
    McCord MR; Bigio EH; Kam KL; Fischer V; Obeidin F; White CL; Brat DJ; Muller WA; Mao Q
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):641-646. PubMed ID: 32346735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3.
    Suga N; Katsuno M; Koike H; Banno H; Suzuki K; Hashizume A; Mano T; Iijima M; Kawagashira Y; Hirayama M; Nakamura T; Watanabe H; Tanaka F; Sobue G
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):628-39. PubMed ID: 23617879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Koeppen AH
    Adv Exp Med Biol; 2018; 1049():233-241. PubMed ID: 29427106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
    Matilla T; McCall A; Subramony SH; Zoghbi HY
    Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmotor and extracerebellar features in Machado-Joseph disease: a review.
    Pedroso JL; França MC; Braga-Neto P; D'Abreu A; Saraiva-Pereira ML; Saute JA; Teive HA; Caramelli P; Jardim LB; Lopes-Cendes I; Barsottini OG
    Mov Disord; 2013 Aug; 28(9):1200-8. PubMed ID: 23775899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Rüb U; Brunt ER; Deller T
    Curr Opin Neurol; 2008 Apr; 21(2):111-6. PubMed ID: 18317266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7).
    Hoche F; Seidel K; Brunt ER; Auburger G; Schöls L; Bürk K; de Vos RA; den Dunnen W; Bechmann I; Egensperger R; Van Broeckhoven C; Gierga K; Deller T; Rüb U
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):479-91. PubMed ID: 18221259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.